Home > Annual Financials > INNOVA CAPTAB

INNOVA CAPTAB Financial Statement Analysis
[BOM: 544067|NSE : INNOVACAP]

The Revenues of INNOVA CAPTAB have increased by 16.72% YoY .
The Earnings Per Share (EPS) of INNOVA CAPTAB has increased by 16.45 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

INNOVA CAPTAB Last 5 Annual Financial Results
[BOM: 544067|NSE : INNOVACAP]

ConsolidatedMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹1,081 Cr₹926 Cr₹801 Cr₹411 Cr₹373 Cr
Expenses ₹927 Cr₹813 Cr₹705 Cr₹356 Cr₹322 Cr
Operating Profit (Excl OI) ₹154 Cr₹114 Cr₹96 Cr₹54 Cr₹51 Cr
Other Income ₹12 Cr₹9.20 Cr₹2.88 Cr₹1.37 Cr₹1.30 Cr
Interest ₹21 Cr₹20 Cr₹5.68 Cr₹3.93 Cr₹4.63 Cr
Depreciation ₹16 Cr₹11 Cr₹7.50 Cr₹5.59 Cr₹10 Cr
Profit Before Tax ₹130 Cr₹92 Cr₹86 Cr₹46 Cr₹38 Cr
Profit After Tax ₹94 Cr₹68 Cr₹64 Cr₹35 Cr₹28 Cr
Consolidated Net Profit ₹94 Cr₹68 Cr₹64 Cr₹34 Cr₹28 Cr
Earnings Per Share (Rs)₹16.49₹14.16₹531.54₹286.86₹232.23
PAT Margin (%)8.717.237.918.387.46
ROE(%)17.0428.0236.1927.0428.92
ROCE(%)19.0624.3430.6428.4226.48
Total Debt/Equity(x)0.290.850.950.310.48

Key Financials

Market Cap : ₹ 4,950.1 Cr
Revenue (TTM) : ₹ 1,243.7 Cr
Net Profit(TTM) : ₹ 128.3 Cr
EPS (TTM) : ₹ 22.4
P/E (TTM) : 38.6

Industry Peers & Returns1W1M1Y
INNOVA CAPTAB -1.9% -7.3% 82%
SUN PHARMACEUTICAL INDUSTRIES 1.4% 0.1% 13.9%
DIVIS LABORATORIES 0.8% 12.3% 47.2%
CIPLA 2.6% -0.1% 0.6%
TORRENT PHARMACEUTICALS 2.7% -0.6% 14.4%
DR REDDYS LABORATORIES 7.8% 12.9% 13.3%
MANKIND PHARMA 1.3% -4.8% 9.3%
ZYDUS LIFESCIENCES 5.4% 11% -7.3%
LUPIN 3.3% -1.7% 22.3%


INNOVA CAPTAB Revenues
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

16.72 %

5 Yr CAGR

30.46 %

Years Revenues % Change
Mar2024 ₹1,081 Cr
16.72
Mar2023 ₹926 Cr
15.72
Mar2022 ₹801 Cr
94.94
Mar2021 ₹411 Cr
10.00
Mar2020 ₹373 Cr -


INNOVA CAPTAB Operating Profit
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

35.91 %

5 Yr CAGR

31.96 %

Years Operating Profit % Change
Mar2024 ₹154 Cr
35.91
Mar2023 ₹114 Cr
18.36
Mar2022 ₹96 Cr
76.23
Mar2021 ₹54 Cr
6.98
Mar2020 ₹51 Cr -

Operating Margins
Y-o-Y

16.38 %

5 Yr CAGR

1.15 %

Years Operating Margin% % Change
Mar2024 14.28%
16.38
Mar2023 12.27%
2.34
Mar2022 11.99%
-9.65
Mar2021 13.27%
-2.71
Mar2020 13.64% -

INNOVA CAPTAB Profit After Tax
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

38.84 %

5 Yr CAGR

35.65 %

Years Profit After Tax % Change
Mar2024 ₹94 Cr
38.84
Mar2023 ₹68 Cr
6.54
Mar2022 ₹64 Cr
85.30
Mar2021 ₹34 Cr
23.53
Mar2020 ₹28 Cr -

PAT Margins
Y-o-Y

20.47 %

5 Yr CAGR

3.95 %

Years PAT Margin(%) % Change
Mar2024 8.71 %
20.47
Mar2023 7.23 %
-8.60
Mar2022 7.91 %
-5.61
Mar2021 8.38 %
12.33
Mar2020 7.46 % -

INNOVA CAPTAB Earnings Per Share (EPS)
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

16.45 %

5 Yr CAGR

-48.38 %

Years EPS % Change
Mar2024 ₹16
16.45
Mar2023 ₹14
-97.34
Mar2022 ₹532
85.30
Mar2021 ₹287
23.52
Mar2020 ₹232 -

INNOVA CAPTAB Return on Capital Employed (ROCE)
[BOM: 544067|NSE : INNOVACAP]

Y-o-Y

-21.69 %

5 Yr CAGR

-7.89 %

Years ROCE % Change
Mar2024 19.06%
-21.69
Mar2023 24.34%
-20.56
Mar2022 30.64%
7.81
Mar2021 28.42%
7.33
Mar2020 26.48% -

INNOVA CAPTAB Share Price vs Sensex

Current Share Price : ₹865.4
Current MarketCap: ₹ 4,950.1 Cr
Updated EOD on :Jun 10,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
INNOVA CAPTAB

-1.9%

-7.3%

82%

SENSEX

2.1%

3.7%

14.3%

INNOVA CAPTAB related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP 3.2% 16.1% 20.7%
BSE HEALTHCARE 2.6% 6% 27%
NSE Indices1W1M1Y
NIFTY MICROCAP 250 3.1% 16.5% 23.9%
NIFTY TOTAL MARKET 2.8% 8% 15.2%
NIFTY IPO INDEX 2.6% 12.1% NA

You may also like the below Video Courses


FAQ about INNOVA CAPTAB Financials


How the annual revenues of INNOVA CAPTAB have changed ?

The Revenues of INNOVA CAPTAB have increased by 16.72% YoY .

How the Earnings per Share (EPS) of INNOVA CAPTAB have changed?

The Earnings Per Share (EPS) of INNOVA CAPTAB has increased by 16.45 % YoY .